Searching over 5,500,000 cases.


searching
Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.

In Re: Wellbutrin Xl Antitrust Litigation

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA


May 11, 2012

IN RE: WELLBUTRIN XL ANTITRUST LITIGATION

The opinion of the court was delivered by: Mary A. McLAUGHLIN, J.

ORDER

AND NOW, this 11th day of May, 2012, upon consideration of the Biovail Defendants' Motion for Summary Judgment (Docket No. 410 in 08-cv-2431; Docket No. 378 in 08-cv-2433), the GSK Defendants' Motion for Summary Judgment (Docket No. 411 in 08-cv-2431; Docket No. 379 in 08-cv-2433), the plaintiffs' consolidated opposition thereto, the defendants' replies in support, the plaintiffs' post-hearing submission, and following oral argument on March 20, 2012, IT IS HEREBY ORDERED, for the reasons stated in a memorandum of law bearing today's date, that the defendants' motions are GRANTED IN PART.

The Court does not decide today the motions for summary judgment as to the settlement transaction. The motions are granted as to the patent infringement lawsuits and the citizen petition.

BY THE COURT:

Mary A. McLaughlin

20120511

© 1992-2012 VersusLaw Inc.



Buy This Entire Record For $7.95

Official citation and/or docket number and footnotes (if any) for this case available with purchase.

Learn more about what you receive with purchase of this case.